Opportunity Information: Apply for CDC RFA GH15 1594

  • The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Improved Quality and Sustainability of Medication Assisted Treatment in Ukraine under the Presidents Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067 Global AIDS.
  • This funding opportunity was created on Aug 28, 2014 and posted on Aug 28, 2014.
  • Applicants must submit their applications by Oct 15, 2014. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $500,000.00 in funding.
  • The number of recipients for this funding is limited to 1 candidate(s).
  • Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
  • Eligible applicants that can apply for this FOA are listed below Government Organizations National Ministries of Health State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) . American Indian/Alaska Native tribal governments (federally recognized or state recognized) Political subdivisions of States (in consultation with States) Non government Organizations American Indian/Alaska native tribally designated organizations Alaska Native health corporations Tribal epidemiology centers Urban Indian health organizations Nonprofit with 501C3 IRS status (other than institution of higher education) Nonprofit without 501C3 IRS status (other than institution of higher education) Research institutions (that will perform activities deemed as non research) Colleges and Universities Community based organizations Faith based organizations For profit organizations (other than small business) Hospitals Small, minority, and women owned businesses All Other eligible organizations
Apply for CDC RFA GH15 1594

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The Centers for Disease Control and Prevention (CDC), using PEPFAR funding, issued this discretionary funding opportunity (CDC-RFA-GH15-1594) to strengthen Medication Assisted Treatment (MAT) programs in Ukraine at a time when donor support for HIV programs was declining. The core purpose is not simply to keep MAT sites operating in the short term, but to provide targeted technical assistance that helps Ukraine move toward more financially sustainable, cost-effective, and higher-quality MAT service delivery. The underlying public health rationale is that MAT is a critical intervention for people with opioid use disorder and is closely tied to HIV prevention and HIV treatment outcomes, particularly in settings where injection drug use has been a major driver of HIV transmission.

The opportunity is structured as a cooperative agreement, meaning CDC would be substantially involved in guiding and collaborating on implementation rather than operating as a hands-off funder. The work is positioned as systems-focused support: improving how MAT is financed, how staff deliver care, how quality is measured and improved, and how MAT is integrated with other essential services. While the listing shows an award ceiling of $500,000 and an expected number of awards of one, the “estimated total funding” field is displayed as 0 in the source data, which can occur in archived listings or when final amounts are determined later. There is no cost sharing or matching requirement.

By the end of the five-year project period, the FOA sets several concrete targets. First, the recipient is expected to identify and implement at least three funding and organizational models that are financially sustainable and cost effective, with the explicit intent that these models can inform future MAT scale-up by the Government of Ukraine. This emphasis signals a shift from externally financed programming toward approaches that can realistically be absorbed into national or subnational budgets and management structures, including more efficient service organization and financing pathways.

Second, the FOA prioritizes improving clinical quality. It requires training at least 60 MAT program personnel on up-to-date clinical standards, and it calls for institutionalizing a clinical quality improvement system. In practice, that means moving beyond one-time trainings and building routine processes that monitor performance and outcomes, identify gaps in care, and implement ongoing improvements across MAT sites. The aim is to raise and standardize the quality of care for all MAT clients, which is especially important when programs are expanding or being transitioned to new funding arrangements.

Third, the opportunity focuses on integrated care, recognizing that MAT clients often have overlapping health needs that strongly influence long-term outcomes. The FOA calls for implementing integrated models that increase the number of MAT clients receiving co-located services, specifically including tuberculosis services, pre-antiretroviral therapy services, and antiretroviral therapy care. Co-location and integration are intended to make it easier for clients to access multiple services in one setting, reduce drop-off between referrals, and ultimately improve both HIV-related and overall health outcomes.

Finally, the FOA addresses what happens after MAT, aiming to reduce relapse among clients who discharge. By year five, the recipient is expected to identify and implement at least two models of post-MAT services. This requirement reflects an understanding that discharge can be a high-risk transition point and that continued support, follow-up, and linkage to other services can significantly affect sustained recovery and health stability.

Eligibility is broad and includes government organizations (such as ministries of health and state/local governments and their agents), tribal governments and tribally designated organizations, nonprofits with or without 501(c)(3) status, research institutions conducting non-research activities, colleges and universities, community- and faith-based organizations, hospitals, and for-profit organizations other than small businesses, among others. The announcement was posted on August 28, 2014, with an original and final closing date of October 15, 2014, and it was archived on November 14, 2014. For access issues, CDC directed applicants to the Procurement and Grants Office Technical Information Management Section (pgotim@cdc.gov, 770-488-2700).

Frequently Asked Questions (FAQs)

1) What is the funding opportunity number for this grant?

The funding opportunity is CDC-RFA-GH15-1594.

2) Which agency is offering this opportunity?

The opportunity is offered by the Centers for Disease Control and Prevention (CDC).

3) What funding source supports this award?

The opportunity uses PEPFAR funding.

4) What is the main purpose of this opportunity?

The purpose is to strengthen Medication Assisted Treatment (MAT) programs in Ukraine by providing targeted technical assistance that helps move MAT services toward more financially sustainable, cost-effective, and higher-quality delivery, especially as donor support for HIV programs was declining.

5) Is the goal simply to keep MAT sites open in the short term?

No. The core purpose is not just short-term continuation of MAT site operations, but systems-focused technical assistance to improve sustainability, efficiency, and service quality.

6) Why is MAT a public health priority in this announcement?

The public health rationale described is that MAT is a critical intervention for people with opioid use disorder and is closely linked to HIV prevention and HIV treatment outcomes, particularly where injection drug use has been a major driver of HIV transmission.

7) What type of award mechanism is used?

This opportunity is structured as a cooperative agreement.

8) What does it mean that this is a cooperative agreement?

It means CDC would be substantially involved in guiding and collaborating on implementation, rather than acting as a hands-off funder.

9) What kinds of activities does the work emphasize?

The work is positioned as systems-focused support, including improving how MAT is financed, how staff deliver care, how quality is measured and improved, and how MAT is integrated with other essential services.

10) What is the project period?

The project period is five years, with several end-of-project targets specified for completion by the end of year five.

11) What is the award ceiling?

The listing shows an award ceiling of $500,000.

12) How many awards are expected?

The listing indicates an expected number of awards of one.

13) Why does the listing show "estimated total funding" as 0?

The source information notes that an "estimated total funding" value of 0 can occur in archived listings or when final amounts are determined later.

14) Is cost sharing or matching required?

No. The opportunity states there is no cost sharing or matching requirement.

15) What sustainability outcomes are required by the end of the project?

By the end of the five-year period, the recipient is expected to identify and implement at least three funding and organizational models that are financially sustainable and cost effective, intended to inform future MAT scale-up by the Government of Ukraine.

16) What does the opportunity say about transitioning from donor funding?

It emphasizes a shift from externally financed programming toward approaches that can realistically be absorbed into national or subnational budgets and management structures, including more efficient service organization and financing pathways.

17) What clinical quality targets are included?

The FOA requires training at least 60 MAT program personnel on up-to-date clinical standards and calls for institutionalizing a clinical quality improvement system.

18) What is meant by "institutionalizing" a clinical quality improvement system?

As described, it means moving beyond one-time trainings by establishing routine processes to monitor performance and outcomes, identify gaps in care, and implement ongoing improvements across MAT sites.

19) What is the goal of the quality improvement focus?

The stated aim is to raise and standardize the quality of care for all MAT clients, which is particularly important during program expansion or transitions to new funding arrangements.

20) Does the opportunity require integrated care models?

Yes. The FOA calls for implementing integrated models that increase the number of MAT clients receiving co-located services.

21) Which co-located services are specifically mentioned?

The opportunity specifically includes tuberculosis services, pre-antiretroviral therapy services, and antiretroviral therapy care as co-located services to be integrated with MAT.

22) What is the intended benefit of co-location and integration?

Co-location and integration are intended to make it easier for clients to access multiple services in one setting, reduce drop-off between referrals, and improve HIV-related and overall health outcomes.

23) Does the FOA address support after clients discharge from MAT?

Yes. It includes a focus on what happens after MAT to reduce relapse among clients who discharge.

24) What post-MAT service requirement is included by year five?

By year five, the recipient is expected to identify and implement at least two models of post-MAT services.

25) Why does the opportunity emphasize post-MAT services?

The description notes that discharge can be a high-risk transition point and that continued support, follow-up, and linkage to other services can significantly affect sustained recovery and health stability.

26) Who is eligible to apply?

Eligibility is broad and includes government organizations (such as ministries of health and state/local governments and their agents), tribal governments and tribally designated organizations, nonprofits with or without 501(c)(3) status, research institutions conducting non-research activities, colleges and universities, community- and faith-based organizations, hospitals, and for-profit organizations other than small businesses, among others.

27) Are for-profit organizations eligible?

Yes. The eligibility list includes for-profit organizations other than small businesses.

28) Are nonprofits required to have 501(c)(3) status to be eligible?

No. The eligibility list includes nonprofits with or without 501(c)(3) status.

29) Are research institutions eligible?

Yes. The eligibility list includes research institutions conducting non-research activities.

30) When was the opportunity posted?

The announcement was posted on August 28, 2014.

31) What were the closing dates?

The original and final closing date listed is October 15, 2014.

32) Is this opportunity still active?

No. The listing indicates it was archived on November 14, 2014.

33) Where is the work focused geographically?

The work described is focused on strengthening MAT programs in Ukraine.

34) Who should applicants contact for access issues related to the announcement?

For access issues, CDC directed applicants to the Procurement and Grants Office Technical Information Management Section at pgotim@cdc.gov or 770-488-2700.

Browse more opportunities from the same agency: Centers for Disease Control and Prevention

Browse more opportunities from the same category: Health

Next opportunity: Capacity Building through Training/Mentoring for Treatment, Care and Support including Preventing Mother to Child Transmission (PMTCT) TB/HIV Health System Strengthening and Voluntary Medical Male Circumcision in Zambia under the Presidents Emergency

Previous opportunity: Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Centers (U54)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for CDC RFA GH15 1594

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (CDC RFA GH15 1594) also looked into and applied for these:

Funding Opportunity
Capacity Building through Training/Mentoring for Treatment, Care and Support including Preventing Mother to Child Transmission (PMTCT) TB/HIV Health System Strengthening and Voluntary Medical Male Circumcision in Zambia under the Presidents Emergency Apply for CDC RFA GH15 1597

Funding Number: CDC RFA GH15 1597
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $6,000,000
Enhancing the Government of Indias Capacity through PEPFAR to Scale Up and Improve Comprehensive HIV Service Package Quality for People Who Inject Drugs under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1542

Funding Number: CDC RFA GH15 1542
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $1,800,000
Administrative Supplements for U.S. Brazil Biomedical Collaborative Research Apply for PA 14 328

Funding Number: PA 14 328
Agency: National Institutes of Health
Category: Health
Funding Amount: $100,000
Implementation of Sustainable Laboratory Quality Systems in the Republic of Kenya under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1544

Funding Number: CDC RFA GH15 1544
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $15,000,000
Quality Data for Decision Making (QDDM) Apply for APS 386 14 000002

Funding Number: APS 386 14 000002
Agency: India USAID New Delhi
Category: Health
Funding Amount: $6,000,000
Implementing Evidence Based Prevention Interventions for Key Populations in the Republic of Rwanda under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1616

Funding Number: CDC RFA GH15 1616
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $1,360,627
Building Institutional Capacity to Improve HIV TB Care and Treatment Service Quality in India under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1540

Funding Number: CDC RFA GH15 1540
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $750,000
Expand Coverage and Improve the Quality of Facility and Community Based Prevention of Mother to Child Transmission of HIV (PMTCT) Support for Rollout of Option B Services in the Littoral and Center Regions of Cameroon under the Presidents Emergency P Apply for CDC RFA GH15 1508

Funding Number: CDC RFA GH15 1508
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $8,000,000
Limited Competition Strategic Timing of Antiretroviral Treatment (START) (UM1) Apply for PAR 14 329

Funding Number: PAR 14 329
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Surveillance, Service Data Analysis and Capacity Building to Support Management, Leadership and Sustainability of HIV Programs in Haiti and other Health Initiatives under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1529

Funding Number: CDC RFA GH15 1529
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $1,250,000
Guyana Civil Society Leadership Project Apply for RFA 538 14 000007

Funding Number: RFA 538 14 000007
Agency: Dominican Republic USAID Santo Domingo
Category: Health
Funding Amount: $500,000
Affordable Care Act Maternal, Infant and Early Childhood Home Visiting Formula Grant Program Apply for HRSA 15 101

Funding Number: HRSA 15 101
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
Affordable Care Act Maternal, Infant and Early Childhood Home Visiting Program Grants Apply for HRSA 15 102

Funding Number: HRSA 15 102
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: $9,400,000
NIMH Career Transition Award for Tenure Track and Tenured Intramural Investigators (K22) Apply for PAR 14 330

Funding Number: PAR 14 330
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Strengthening of the Human Resources Information System and Development of Open Health Information Enterprise Architecture in the Republic of Zimbabwe under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1604

Funding Number: CDC RFA GH15 1604
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $600,000
Enhancing Strategic Information Capacity for HIV/AIDS Programs in Kenya through Surveillance and Epidemiology, Monitoring and Evaluation and Mobile Health Solutions under the U.S. Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1543

Funding Number: CDC RFA GH15 1543
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $9,800,000
Comprehensive High Impact HIV Prevention Projects for Community Based Organizations Apply for CDC RFA PS15 1502

Funding Number: CDC RFA PS15 1502
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $450,000
Strengthening Laboratory and Blood Transfusion Services in South Sudan under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1571

Funding Number: CDC RFA GH15 1571
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $1,200,000
Information System Development and Systems Integration Support for National HIV and Health Sector Systems in the Republic of Tanzania under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1586

Funding Number: CDC RFA GH15 1586
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $900,000
Partnership for State Title V Maternal and Child Health Leadership Community Cooperative Agreement Apply for HRSA 15 071

Funding Number: HRSA 15 071
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: $1,537,500

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH15 1594", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.